Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion type Assertion NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_head.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion description "[The aberrant expression of KLKs, presented in many human malignancies, highlights the significance of this gene family for early diagnosis, prognosis and monitoring of cancer patients, as it is strongly emphasized by the routine use of PSA (KLK3) for prostate cancer management.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_provenance.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion evidence source_evidence_literature NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_provenance.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion SIO_000772 20302518 NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_provenance.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion wasDerivedFrom befree-2016 NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_provenance.
- NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_assertion wasGeneratedBy ECO_0000203 NP801055.RA6Bkol8YL345VnXVuLoli34tyHTNRwKc9ZtypLYrn_M0130_provenance.